Muscarinic acetylcholine receptor-dependent induction of persistent synaptic enhancement in rat hippocampus in vivo

Neuroscience

Volumn 144, Issue 2, 2007, Pages 754-761

  Li, S ^a   Cullen, W K ^a   Anwyl, R ^a   Rowan, M J ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

cholinergic autoreceptor; excitatory postsynaptic potential; long term potentiation; muscarinic receptor

Indexed keywords

4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; ACETYLCHOLINE; METHOCTRAMINE; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; OTENZEPAD; TELENZEPINE;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC ACTIVITY; CONTROLLED STUDY; DRUG RECEPTOR BINDING; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPUS; LONG TERM POTENTIATION; MALE; NERVE CELL PLASTICITY; NONHUMAN; POSTSYNAPTIC POTENTIAL; PRIORITY JOURNAL; RAT; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR SENSITIVITY; SYNAPTIC TRANSMISSION;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; HIPPOCAMPUS; LONG-TERM POTENTIATION; MALE; MEMBRANE POTENTIALS; MUSCARINIC ANTAGONISTS; NICOTINIC ANTAGONISTS; PRESYNAPTIC TERMINALS; RATS; RATS, WISTAR; RECEPTORS, MUSCARINIC; TIME FACTORS;

EID: 33845226397     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.10.001     Document Type: Article

References (56)

1. Apartis E., Poindessous-Jazat F.R., Lamour Y.A., and Bassant M.H. Loss of rhythmically bursting neurons in rat medial septum following selective lesion of septohippocampal cholinergic system. J Neurophysiol 79 (1998) 1633-1642
2. Auerbach J.M., and Segal M. Muscarinic receptors mediating depression and long-term potentiation in rat hippocampus. J Physiol 492 (1996) 479-493
3. Aura J., Sirvio J., and Riekkinen P. Methoctramine moderately improves memory but pirenzepine disrupts performance in delayed non-matching to position test. Eur J Pharmacol 333 (1997) 129-134
4. Baratti C.M., Opezzo J.W., and Kopf S.R. Facilitation of memory storage by the acetylcholine-M(2) muscarinic receptor antagonist-AF-DX-116. Behav Neural Biol 60 (1993) 69-74
5. Brazhnik E.S., and Fox S.E. Action potentials and relations to the theta rhythm of medial septal neurons in vivo. Exp Brain Res 127 (1999) 244-258
6. Burgard E.C., and Sarvey J.M. Muscarinic receptor activation facilitates the induction of long-term potentiation (LTP) in the rat dentate gyrus. Neurosci Lett 116 (1990) 34-39
7. Carey G.J., Billard W., Binch H., Cohen-Williams M., Crosby G., Grzelak M., Guzik H., Kozlowski J.A., Lowe D.B., Pond A.J., Tedesco R.P., Watkins R.W., and Coffin V.L. SCH 57790, a selective muscarinic M-2 receptor antagonist, releases acetylcholine and produces cognitive enhancement in laboratory animals. Eur J Pharmacol 431 (2001) 189-200
8. Caulfield M.P. Muscarinic receptors: characterization, coupling and function. Pharmacol Ther 58 (1993) 319-379
9. Doods H.N., Mathy M.J., Davidesko D., van Charldorp K.J., de Jonge A., and van Zwieten P.A. Selectivity of muscarinic antagonists in radioligand and in vivo experiments for the putative M1, M2 and M3 receptors. J Pharmacol Exp Ther 242 (1987) 257-262
10. Fernandez de Sevilla D., and Buno W. Presynaptic inhibition of Schaffer collateral synapses by stimulation of hippocampal cholinergic afferent fibres. Eur J Neurosci 17 (2003) 555-558
11. Ferreira A.R., Furstenau L., Blanco C., Kornisiuk E., Sanchez G., Daroit D., Castro e Silva M., Cervenansky C., Jerusalinsky D., and Quillfeldt J.A. Role of hippocampal M1 and M4 muscarinic receptor subtypes in memory consolidation in the rat. Pharmacol Biochem Behav 74 (2003) 411-415
12. Galli R.L., Fine R.E., Thorpe B.C., Hale B.S., and Lieberman H.R. Antisense oligonucleotide sequences targeting the muscarinic type 2 acetylcholine receptor enhance performance in the Morris water maze. Int J Neurosci 103 (2000) 53-68
13. Galvan M., Boer R., and Schudt C. Interaction of telenzepine with muscarinic receptors in mammalian sympathetic-ganglia. Eur J Pharmacol 167 (1989) 1-10
14. Grover L., and Teyler T. Two components of long-term potentiation induced by different patterns of afferent activation. Nature 347 (1990) 477-479
15. Hamilton S.E., and Nathanson N.M. The M-1 receptor is required for muscarinic activation of mitogen-activated protein (MAP) kinase in murine cerebral cortical neurons. J Biol Chem 276 (2001) 15850-15853
16. Huerta P.T., and Lisman J.E. Heightened synaptic plasticity of hippocampal CA1 neurons during a cholinergically induced rhythmic state. Nature 364 (1993) 723-725
17. Kikusui T., Aoyagi A., and Kaneko T. Spatial working memory is independent of hippocampal CA1 long-term potentiation in rats. Behav Neurosci 114 (2000) 700-706
18. Kim J., Isokawa M., Ledent C., and Alger B. Activation of muscarinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus. J Neurosci 22 (2002) 10182-10191
19. Kitaichi K., Hori T., Srivastava L.K., and Quirion R. Antisense oligodeoxynucleotides against the muscarinic m(2), but not m(4), receptor supports its role as autoreceptors in the rat hippocampus. Mol Brain Res 67 (1999) 98-106
20. Kopf S.R., Boccia M.M., and Baratti C.M. AF-DX 116, a presynaptic muscarinic receptor antagonist, potentiates the effects of glucose and reverses the effects of insulin on memory. Neurobiol Learn Mem 70 (1998) 305-313
21. Lazaris A., Cassel S., Stemmelin J., Cassel J.C., and Kelche C. Intrastriatal infusions of methoctramine improve memory in cognitively impaired aged rats. Neurobiol Aging 24 (2003) 379-383
22. Leung L.S., Shen B.X., Rajakumar N., and Ma J.Y. Cholinergic activity enhances hippocampal long-term potentiation in CA1 during walking in rats. J Neurosci 23 (2003) 9297-9304
23. Li S., Anwyl R., and Rowan M.J. A persistent reduction in short-term facilitation accompanies long-term potentiation in the CA1 area in the intact hippocampus. Neuroscience 100 (2000) 213-220
24. Lin Y.W., Yang H.W., Min M.Y., and Chiu T.H. Heat-shock pretreatment prevents suppression of long-term potentiation induced by scopolamine in rat hippocampal CA1 synapses. Brain Res 999 (2004) 222-226
25. Marino M.J., Rouse S.T., Levey A.I., Potter L.T., and Conn P.J. Activation of the genetically defined m1 muscarinic receptor potentiates N-methyl-D-aspartate (NMDA) receptor currents in hippocampal pyramidal cells. Proc Natl Acad Sci U S A 95 (1998) 11465-11470
26. Markram H., and Segal M. Activation of protein-kinase-C suppresses responses to NMDA in Rat CA1 hippocampal-neurons. J Physiol 457 (1992) 491-501
27. Messer W.S., and Miller M.D. Intrahippocampal injections of gallamine impair learning of a memory task. Neurosci Lett 89 (1988) 367-372
28. Michel A.D., Stefanich E., and Whiting R.L. Direct labeling of rat M3-muscarinic receptors by [3H]4DAMP. Eur J Pharmacol 166 (1989) 459-466
29. Michel A.D., and Whiting R.L. Methoctramine, a polymethylene tetraamine, differentiates 3 subtypes of muscarinic receptor in direct binding-studies. Eur J Pharmacol 145 (1988) 61-66
30. Morris R.G.M., Moser E.I., Riedel G., Martin S.J., Sandin J., Day M., and O'Carroll C. Elements of a neurobiological theory of the hippocampus: the role of activity-dependent synaptic plasticity in memory. Philos Trans R Soc Lond B Biol Sci 358 (2003) 773-786
31. Nikbakht M., and Stone T. Occlusive responses to adenosine A1 receptor and muscarinic M2 receptor activation on hippocampal presynaptic terminals. Brain Res 829 (1999) 193-196
32. Ohno M., Yamamoto T., and Watanabe S. Blockade of hippocampal M(1) muscarinic receptors impairs working-memory performance of rats. Brain Res 650 (1994) 260-266
33. Packard M.G., Regenold W., Quirion R., and White N.M. Post-training injection of the acetylcholine M2 receptor antagonist AF-DX 116 improves memory. Brain Res 524 (1990) 72-76
34. Parent M.B., and Baxter M.G. Septohippocampal acetylcholine: Involved in but not necessary for learning and memory?. Learn Mem 11 (2004) 9-20
35. Pike B.R., and Hamm R.J. Postinjury administration of BIBN-99, a selective muscarinic M(2) receptor antagonist, improves cognitive performance following traumatic brain injury in rats. Brain Res 686 (1995) 37-43
36. Quirion R., Wilson A., Rowe W., Aubert I., Richard J., Doods H., Parent A., White N., and Meaney M.J. Facilitation of acetylcholine-release and cognitive performance by an M(2)-muscarinic receptor antagonist in aged memory-impaired rats. J Neurosci 15 (1995) 1455-1462
37. Rouse S.T., Edmunds S.M., Yi H., Gilmor M.L., and Levey A.I. Localization of M-2 muscarinic acetylcholine receptor protein in cholinergic and non-cholinergic terminals in rat hippocampus. Neurosci Lett 284 (2000) 182-186
38. Rouse S.T., Thomas T.M., and Levey A.I. Muscarinic acetylcholine receptor subtype, m2: Diverse functional implications of differential synaptic localization. Life Sci 60 (1997) 1031-1038
39. Rowe W.B., O'Donnell J.P., Pearson D., Rose G.M., Meaney M.J., and Quirion R. Long-term effects of BIBN-99, a selective muscarinic M2 receptor antagonist, on improving spatial memory performance in aged cognitively impaired rats. Behav Brain Res 145 (2003) 171-178
40. Sarter M., and Bruno J.P. Cognitive functions of cortical acetylcholine: toward a unifying hypothesis. Brain Res Brain Res Rev 23 (1997) 28-46
41. Seeger T., and Alzheimer C. Muscarinic activation of inwardly rectifying K+ conductance reduces EPSPs in rat hippocampal CA1 pyramidal cells. J Physiol 535 (2001) 383-396
42. Seeger T., Fedorova I., Zheng F., Miyakawa T., Koustova E., Gomeza J., Basile A.S., Alzheimer C., and Wess J. M-2 muscarinic acetylcholine receptor knock-out mice show deficits in behavioral flexibility, working memory, and hippocampal plasticity. J Neurosci 24 (2004) 10117-10127
43. Segal M., and Auerbach J.M. Muscarinic receptors involved in hippocampal plasticity. Life Sci 60 (1997) 1085-1091
44. Shimoshige Y., Maeda T., Kaneko S., Akaike A., and Satoh M. Involvement of M2 receptor in an enhancement of long-term potentiation by carbachol in Schaffer collateral-CA1 synapses of hippocampal slices. Neurosci Res 27 (1997) 175-180
45. Shinoe T., Matsui M., Taketo M., and Manabe T. Modulation of synaptic plasticity by physiological activation of M1 muscarinic acetylcholine receptors in the mouse hippocampus. J Neurosci 25 (2005) 11194-11200
46. Sokolov M.V., and Kleschevnikov A.M. Atropine suppresses associative LTP in the CA1 region of rat hippocampal slices. Brain Res 672 (1995) 281-284
47. Stillman M.J., ShukittHale B., Galli R.L., Levy A., and Lieberman H.R. Effects of M(2) antagonists on in vivo hippocampal acetylcholine levels. Brain Res Bull 41 (1996) 221-226
48. Stillman M.J., Shukitthale B., Kong R.M., Levy A., and Lieberman H.R. Elevation of hippocampal extracellular acetylcholine levels by methoctramine. Brain Res Bull 32 (1993) 385-389
49. Tanaka Y., Sakurai M., and Hayashi S. Effect of scopolamine and HP-029, a cholinesterase inhibitor, on long-term potentiation in hippocampal slices of the guinea-pig. Neurosci Lett 98 (1989) 179-183
50. Tani Y., Saito K., Imoto M., and Ohno T. Pharmacological characterization of nicotinic receptor-mediated acetylcholine release in rat brain: an in vivo microdialysis study. Eur J Pharmacol 351 (1998) 181-188
51. Tombaugh G., Rowe W., Chow A., Michael T., and Rose G. Theta-frequency synaptic potentiation in CA1 in vitro distinguishes cognitively impaired from unimpaired aged Fischer 344 rats. J Neurosci 22 (2002) 9932-9940
52. Tzavaral E.T., Bymaster F.P., Felder C.C., Wade M., Gomeza J., Wess J., McKinzie D.L., and Nomikos G.G. Dysregulated hippocampal acetylcholine neurotransmission and impaired cognition in M2, M4 and M2/M4 muscarinic receptor knockout mice. Mol Psychiatry 8 (2003) 673-679
53. Vannucchi M.G., Scali C., Kopf S.R., Pepeu G., and Casamenti F. Selective muscarinic antagonists differentially affect in vivo acetylcholine release and memory performances of young and aged rats. Neuroscience 79 (1997) 837-846
54. Yun S.H., Cheong M.Y., Mook-Jung I., Huh K., Lee C.J., and Jung M.W. Cholinergic modulation of synaptic transmission and plasticity in entorhinal cortex and hippocampus of the rat. Neuroscience 97 (2000) 671-676
55. Zhang W.L., Basile A.S., Gomeza J., Volpicelli L.A., Levey A.I., and Wess J. Characterization of central inhibitory muscarinic autoreceptors by the use of muscarinic acetylcholine receptor knock-out mice. J Neurosci 22 (2002) 1709-1717
56. Zheng F., Gingrich M.B., Traynelis S.F., and Conn P.J. Tyrosine kinase potentiates NMDA receptor currents by reducing tonic zinc inhibition. Nat Neurosci 1 (1998) 185-191